MMWR: Notice to Readers: Use of Short-Course Tuberculosis Preventive Therapy Regimens in HIV-Seronegative Persons
1998
-
This report in the form of a notice to readers states that CDC in conjunction with the American Thoracic Society expects to issue new guidelines on screening and preventive therapy for TB that will include a recommendation on the use of the two-month regimen of daily rifampin and pyrazinamide (...



